Results

Total Results: 2,146 records

Showing results for "factor".

141. Health Facilities | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/health-facilities
     November 15, 2011 - May 25, 2012 Utilization and Clinical Data on In-Hospital Off-Label Uses of Recombinant Factor

142. Drugs and Young People | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/health-topics/drugs-and-young-people
     January 17, 2012 - Strategies To Improve Cardiovascular Risk Factors in People With Serious Mental Illness: A Comparative Effectiveness Review Research Protocol Archived January 17, 2012 Strategies for Improving the Lives of Women Aged 40 and Above Living with HIV/AIDS Research Protocol Archived Marc…

143. Dia 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/ijzerman_ahrq-webinar-mcda.pdf
     January 01, 2011 - scenarios and if a respondent picks all these scenarios we can assume Thai food is an important factor

144. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - Neither higher than recommended target Hb nor any other single patient- or treatment- related factor … select patients or predict responses to treatment Available evidence does not identify any single factor

145. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-frameworks.ppt
     June 01, 2012 - screen-film mammography in breast cancer screening Project 2 (add-on test): Human epidermal growth factor … replacement for screening film mammography. - The add-on test example uses a human epidermal growth factor … Initial ambiguous claim: Amplification and protein expression assays of the human epidermal growth factor … It involves the use of a human epidermal growth factor receptor 2 (HER2) gene amplification assay after … a refined claim that patients with equivocal results for over expression of human epidermal growth factor

146. PowerPoint Presentation (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-frameworks.ppt
     June 01, 2012 - screen-film mammography in breast cancer screening Project 2 (add-on test): Human epidermal growth factor … replacement for screening film mammography. - The add-on test example uses a human epidermal growth factor … Initial ambiguous claim: Amplification and protein expression assays of the human epidermal growth factor … It involves the use of a human epidermal growth factor receptor 2 (HER2) gene amplification assay after … a refined claim that patients with equivocal results for over expression of human epidermal growth factor

147. Drug Therapy for Early Rheumatoid Arthritis in Adults – An Update | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/rheumatoid-arthritis-medicine-update/research-protocol
     May 24, 2017 - Rates of RA development are increased in monozygotic twins, implicating genetics as a contributing factor … disease activity remains moderate or high, double or triple combination DMARDs or a tumor necrosis factor … Food and Drug Administration; RA = rheumatoid arthritis; TNF = tumor necrosis factor; ts = targeted synthetic … disease-modifying antirheumatic drug; KQ = Key Question; RA = rheumatoid arthritis; TNF = tumor necrosis factor … rheumatoid arthritis; RCT = randomized controlled trial; SR = systematic review; TNF = tumor necrosis factor

148. - (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cystic-fibrosis-hgh_appendixes.pdf
     January 01, 2009 - Modulating effect of human growth hormone on tumour necrosis factor-alpha and interleukin- 1beta. … Growth hormone therapy does not alter the insulin-like growth factor-I/insulin-like growth factor … Insulin-Like Growth Factor 1 (IGF-1): Protein hormone responsible for growth and development. … growth factors including insulin-like growth factor 1 (IGF-1). … Stature as a prognostic factor in cystic fibrosis survival.

149. Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/mental-illness-heart/research
     April 22, 2013 - Current Page Topic Timeline Oct. 28, 2011 Topic Initiated Jan. 17, 2012 Research Protocol Apr. 22, 2013 Systematic Review Aug. 9, 2013 Disposition of Comments Report Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness Systematic Review Archived April 22, 2013 Web Version [NLM…

150. Disparities and Barriers for Pediatric Cancer Survivorship Care | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/pediatric-cancer-survivorship/protocol
     June 24, 2020 - studies may report associations with participant characteristics, e.g., reporting correlations with a factor … AND (“inequit*” OR “disparit*” OR “inequal*”)) OR ((“social*” OR “sociolog*” OR “sociology*”) AND (“factor … disparity OR disparities OR inequality OR inequalities)) OR ((social OR sociological OR sociology) AND (factor

151. PICO #1 Population(s): Children with infantile hemangiomas (IHs) Intervention(s): Early referral Comparator(s): Delayed referral Outcomes(s): Minimization of functional impairment and/or cosmetic deformity PICO #2 Population(s): Children… | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/pico-1-populations-children-with-infantile-hemangiomas-ihs-interventions-early-referral-comparators-delayed-referral-outcomess-minimization-of-functional-impairment-andor-cosmetic-deformity-pico-2-populations-children-with
     November 14, 2013 - science and clinical researchers in IH identified early specialist referral as the single most important factor

152. Topic Suggestion Description | Effective Health Care Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/what-is-the-comparative-effectiveness-of-various-local-treatments-for-1-unresectable-liver-metastases-and-2-unresectable-localized-hepatocellular-carcinoma-hcc-does-the-comparative-effectiveness-vary-when-lesions-are-unresect
     January 07, 2011 - In studying relative risks and benefits, it will likely be important to factor in the reason a tumor

153. Antiplatelet and Anticoagulant Treatments for Unstable Angina/Non-ST Elevation Myocardial Infarction | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/angina-heart-attack-treatments/research-protocol
     December 13, 2012 - Fondaparinuxis an indirect factor Xa inhibitor that is injected subcutaneously on a daily basis. … effient[tw] OR ticagrelor[supplementary concept] OR ticagrelor[tw] OR brilinta[tw] 121676 #3 factor … xa[mesh] OR "factor xa inhibitor"[tw] OR "factor xa inhibitors"[tw] OR rivaroxaban[Supplementary Concept … effient[tw] OR ticagrelor[supplementary concept] OR ticagrelor[tw] OR brilinta[tw] 121676 #3 factor … xa[mesh] OR "factor xa inhibitor"[tw] OR "factor xa inhibitors"[tw] OR rivaroxaban[Supplementary Concept

154. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - Fondaparinux is an indirect factor Xa inhibitor that is injected subcutaneously on a daily basis. … OR effient[tw] OR ticagrelor[supplementary concept] OR ticagrelor[tw] OR brilinta[tw] 121676 #3 factor … xa[mesh] OR "factor xa inhibitor"[tw] OR "factor xa inhibitors"[tw] OR rivaroxaban[Supplementary Concept … OR effient[tw] OR ticagrelor[supplementary concept] OR ticagrelor[tw] OR brilinta[tw] 121676 #3 factor … xa[mesh] OR "factor xa inhibitor"[tw] OR "factor xa inhibitors"[tw] OR rivaroxaban[Supplementary Concept

155. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/methodsguide_conductingquantitativesynthesis.pdf
     October 01, 2010 - events become more frequent (5 percent to10 percent), the Mantel-Haenszel method (without correction factor … Considerations of correction factor for studies with zero events in one arm. … method, the Mantel-Haenszel method, or a logistic regression approach, without adding a correction factor … For the Mantel-Haenszel method, a correction factor of 0.5 is not recommended but using no correction … factor or alternative correction factors could be considered, and investigated in sensitivity analyses

156. Conducting Quantitative Synthesis when Comparing Medical Interventions: AHRQ and the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-quantitative-synthesis_methods.pdf
     October 01, 2010 - events become more frequent (5 percent to10 percent), the Mantel-Haenszel method (without correction factor … Considerations of correction factor for studies with zero events in one arm. … method, the Mantel-Haenszel method, or a logistic regression approach, without adding a correction factor … For the Mantel-Haenszel method, a correction factor of 0.5 is not recommended but using no correction … factor or alternative correction factors could be considered, and investigated in sensitivity analyses

157. Development of Quality Criteria To Evaluate Nontherapeutic Studies of Incidence, Prevalence, or Risk Factors of Chronic Diseases: Pilot Study of New Checklists | Effective Health Care Program
     effectivehealthcare.ahrq.gov/products/asthma-immunotherapy-2011
     February 01, 2011 - Development of Quality Criteria To Evaluate Nontherapeutic Studies of Incidence, Prevalence, or Risk Factors of Chronic Diseases: Pilot Study of New Checklists Timeline January 31, 2011 Topic Initiated February 01, 2011 Research Report Development of Quality…

158. Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/sodium-potassium
     March 01, 2017 - Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Related Risk Factors Timeline August 30, 2016 Topic Initiated March 01, 2017 Research Protocol Effects of Dietary Sodium and Potassium Intake on Chronic Disease Outcomes and Relat…

159. A Framework for "Best Evidence" Approaches in Systematic Reviews | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/methods-guidance-approaches/research
     June 17, 2011 - A Framework for "Best Evidence" Approaches in Systematic Reviews Research Report June 17, 2011 Web Version [NLM Site] Download Main Document PDF 193.2 KB Persons using assistive technology may not be able to fully access information in this file. For assistance, please contact us . Structured Abstrac…

160. Disparities-Quality-Improvement Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_executive.pdf
     August 01, 2012 - One study of cardiovascular risk factor modification showed no meaningful reduction in health disparities … Cardiovascular Disease Studies of CAD risk factor control included men with CAD risk factors at clinical … The interventions for CAD risk factor control included intensive patient education and self-management … For studies of cardiovascular risk factor control, outcomes consisted of intermediate clinical variables … Responses of black and white males to the special intervention program of the Multiple Risk Factor